NASDAQ NMS - GLOBAL MARKET · SRZN
-2.30% · -$0.3900 · Vol 190.2K
Market closed · last close 4:00 PM ET · price as of 16:01:00 ET
Surrozen Inc

Surrozen Inc

Biotechnology
$16.55
Card
Relationship Map

Follow $SRZN

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $SRZN by email

Veridion Score

BETALOW CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
SRZN
Surrozen Inc
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Lowest range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

20/ 100
Veridion Score
Lowest range · LOW confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is SRZN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading SRZN catalysts
About Surrozen Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2021
Employees
44
Country
US

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$16.97
Day high
$17.68
Day low
$16.43
Previous close
$16.94
52W high
$34.13
-51.51% from high
52W low
$11.56
22% of range
Market cap
$199.1M
EPS
$-17.8700
Beta
1.39
Shares out
11.8M
Volume
190.2K
0.95× rel vol
Avg volume
199.8K
VWAP
$16.80
Price history computed in-house
1W
-12.89%
1M
-29.57%
3M
-28.82%
1Y
+34.77%
YTD
-26.77%
SMA 50 $21.81 · below
SMA 200 $24.25 · below
52W position 22%

SRZN overview

Veridion Score
20
Registered · 2026-09-18
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around SRZN.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading SRZN Form 4 filings
Public disclosures

Congress activity in SRZN

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for SRZN in the cached public ledger.

Federal contracts

SRZN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for SRZN in this window.
Lobbying spend

SRZN lobbying filings, year to date.

Registered lobbying filings matched to Surrozen Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for SRZN in this window.
Loading news for SRZN
Analyst ratings
Sovereign unlock shows live analyst consensus for SRZN.
Options
Sovereign unlock shows live options positioning for SRZN.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.